Clinical Trial

Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR

Study acronym: ECHOCATH
Recruiting
View on ClinicalTrials.gov →
Summary
Data on valve performance following ViV-TAVR has usually been obtained with the use of Doppler-echocardiography. However, some reports have shown significant discordances in the evaluation of mean transvalvular gradient between echocardiography and catheterization, with an overestimation of the real gradient with echo (vs. cath) in most cases. Thus, the incidence of procedural-device failure may be lower than that reported in the ViV-TAVR literature,
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-07-12; most recent amendment 2026-03-23.
Status change: Not Yet Recruiting → Recruiting 2023-12-19
Trial Details
NCT Number NCT05459233
Lead Sponsor Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Conditions Aortic Valve Stenosis, Aortic Valve Regurgitation, Prosthesis Failure
Enrollment 310 participants
Start Date 2023-01-11
Primary Completion 2027-09-01 (estimated)
Study Completion 2029-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-24